PHARMAEXPRESS
0743.800.651 · rovalta.com · 08/11/2026
PHARMAEXPRESS
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMAEXPRESS is a Private limited company incorporated in 2020. Its main activity is: Computer consultancy activities. Its registered office is in Thimister-Clermont. It employs on average 2,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0743.800.651
- Incorporation
- 18/02/2020
- Legal form
- Private limited company
- Registered office
- Rue de l'Avenir 12
4890 Thimister-Clermont · WallonieSee on map - Contributed capital
- 500 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,0 ETP
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 428,7 k € | -45.2% | 781,8 k € | -4.3% | 816,7 k € | -57.1% | 1,9 M € | +96.1% | 970,9 k € |
| EBITDA | 188,9 k € | -41.6% | 323,5 k € | +505% | -79,8 k € | -876% | -8,2 k € | +93.4% | -123 k € |
| Operating result | 188,9 k € | -40.8% | 319 k € | +341% | -132,2 k € | -125% | -58,7 k € | +66.2% | -173,4 k € |
| Net result | 162,6 k € | -48.5% | 315,7 k € | +361% | -120,9 k € | -114% | -56,5 k € | +67.5% | -173,6 k € |
| Balance sheet | |||||||||
| Equity | 576,3 k € | +39.3% | 413,7 k € | +322% | 97,9 k € | -55.3% | 218,9 k € | -20.5% | 275,3 k € |
| Total assets | 582,2 k € | +5.0% | 554,6 k € | +162% | 211,6 k € | -44.7% | 382,4 k € | -32.4% | 565,5 k € |
| Cash | 459,8 € | +125% | 204 € | -86.8% | 1,5 k € | -93.1% | 22,6 k € | +536% | 3,5 k € |
| Debts | 5,9 k € | -95.8% | 140,9 k € | +24.0% | 113,6 k € | -30.5% | 163,5 k € | -43.6% | 290,2 k € |
| Other | |||||||||
| Workforce | 2,0 ETP | -45.9% | 3,7 ETP | +164% | 1,4 ETP | +75.0% | 0,8 ETP | -20.0% | 1,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 14/02/2020 | |||
PIERRE LAFLEUR | Directorsince 14/02/2020 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
JACQUES GERCKENS | Director01/04/2021 → 2022 accounts | ||
MARC BREYER | Director14/02/2020 → 2022 accounts | ||
| Managing director14/02/2020 → 2020 accounts |
Other companies at this address
Rue de l'Avenir 12 4890 Thimister-Clermont| Company | CBE no. |
|---|---|
GENERATION 2000● Active | 0432.862.104 |
La Grande Pharmacie● Active | 0402.353.129 |
PHARMACIE DOUCET-STAS● Active | 0859.769.297 |
PHARMACIE LARDINOIS● Active | 0420.259.329 |
| 0402.307.894 | |
PHARMA FUTUR● Active | 0787.394.827 |
SANTIS PHARMA● Active | 0421.562.592 |
V-IMMO● Active | 0461.767.213 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/04/2026 | 19/05/2025 | 14/05/2024 | 25/04/2023 | 29/04/2022 | 11/05/2021 |
| General meeting | 27/04/2026 | 28/04/2025 | 22/04/2024 | 24/04/2023 | 25/04/2022 | 26/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/04/2026 | 28/04/2026 | French | |
| Abridged model | 31/12/2024 | 28/04/2025 | 19/05/2025 | French | |
| Abridged model | 31/12/2023 | 22/04/2024 | 14/05/2024 | French | |
| Abridged model | 31/12/2022 | 24/04/2023 | 25/04/2023 | French | |
| Abridged model | 31/12/2021 | 25/04/2022 | 29/04/2022 | French | |
| Abridged model | 31/12/2020 | 26/04/2021 | 11/05/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 14/02/2020 | |||
PIERRE LAFLEUR | Directorsince 14/02/2020 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
JACQUES GERCKENS | Director01/04/2021 → 2022 accounts | ||
MARC BREYER | Director14/02/2020 → 2022 accounts | ||
| Managing director14/02/2020 → 2020 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de l'Avenir 12, 4890 Thimister-ClermontCurrent | CBE | |
| Rue de Mangombroux 161, 4800 Verviers | accounts 2021 → 2025 | Accounts 2025 · 2026-00094506 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMAEXPRESSCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00094506 |
Events
- 2025Annual accounts 2025162,6 k €↓
- 2024Annual accounts 2024315,7 k €↑
- 2023Annual accounts 2023-120,9 k €↓
- 2022Annual accounts 2022-56,5 k €↑
- 2021Annual accounts 2021-173,6 k €↓
- 2020Annual accounts 2020-51,1 k €
- 18/02/2020IncorporationPrivate limited company